MedTrace Logo

Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.

NCT05120973 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2024-07-29

No results posted yet for this study

Summary

Multispectral imaging of the lymphatic draining pattern of the tumor and the abdominall wall/lower limb to evaluate technical feasibility to differentiate these patterns and in the future reduce the amount of complications that result from damage to lymphatic structures.

Conditions

Interventions

PROCEDURE

multispectral imaging

Sentinel node biopsy with Indocyanine Green -Technetium - Nanocolloid + fluorescein

PROCEDURE

fluorescence for lymphatic mapping

Indocyanine green injected in abdominal wall

Sponsors & Collaborators

  • The Netherlands Cancer Institute

    lead OTHER

Principal Investigators

  • Henk van der Poel, Prof. MD · NKI-AvL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2024-04-25
Completion
2024-07-24

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05120973 on ClinicalTrials.gov